Patent · US Active

Stable aqueous formulations of adalimumab

US9340611B2 · kind B2 · utility

40Cited by
7References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 10, 2015
Grant dateMay 17, 2016
Priority date—
Expiry dateMar 10, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.